Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2022-05-23 Board/Management Inform…
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial results/Fund raising
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about a scheduled Board Meeting on 30th May 2022. The agenda includes approval of audited financial results for the quarter and year ended 31st March 2022, and a proposal for raising funds through various financial instruments subject to shareholder approval. The document also mentions the closure and reopening of the trading window. This is a notification about an upcoming board meeting and its agenda, not the actual financial results or fund raising event. It fits the category of Board/Management Information (MANG) as it relates to board meeting announcements and management decisions.
2022-05-23 English
Spurt in Volume
Regulatory Filings Classification · 100% confidence The document text is extremely short (74 characters) and contains no substantive content, only placeholders and an omitted picture. There is no financial data, report content, or announcement text. Given the lack of any meaningful information, this document does not fit any specific report category and defaults to the fallback category for miscellaneous or non-informative filings.
2022-05-18 English
General updates
Capital/Financing Update Classification · 95% confidence The document is a statement on deviation or variation of funds raised through a Rights Issue for the quarter ended 31st March 2022. It confirms no deviation in the utilization of issue proceeds and includes details about the fund raising, monitoring agency, and usage of funds. The document references SEBI regulations and is a compliance disclosure related to capital raising activities. It is not a full financial report, audit report, or earnings release, but an update on the use of funds raised through a Rights Issue. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 3660 characters, which is consistent with a detailed update rather than a brief announcement or a full report.
2022-05-15 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended 31st March, 2022' and is issued pursuant to SEBI regulations related to the monitoring of proceeds from a Rights Issue. It contains detailed information on the utilization of issue proceeds, deviations, issuer details, and certifications by a monitoring agency. The document is a formal report on the use of capital raised through a rights issue, including financial data and compliance with regulatory requirements. It is not an announcement or a brief summary but a substantive report with financial and compliance details. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2022-05-15 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI regulations about disclosure requirements. The content is about share certificate replacement, which is a capital-related administrative update but does not involve new share issuance, stock splits, or capital structure changes. It is not a financial report, earnings release, or management discussion. It is also not a director's dealing or major shareholding notification. The document is a regulatory announcement related to share certificates, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2022-05-10 English
Loss of share certificate
Regulatory Filings
2022-04-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.